Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee

Mandy Flannery O'Leary, Nancy M. Dunbar, Haewon C. Kim, Nicole L. Draper, Michael Linenberger, Joseph Schwartz, Yvette Miller, Ally Murtaugh, F. Bernadette West, Leonor P Fernando, Yara A. Park

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose:: Hematopoietic Progenitor Cell (HPC) collection by apheresis is performed in patients and donors to obtain HPCs for transplantation. Although studies have shown these procedures to be safe, successful collection cannot be performed without establishment of venous access. This project's objective was to ascertain the current practices of donor vein assessment and central venous catheter (CVC) usage. Methods: The American Society for Apheresis (ASFA) HPC subcommittee created an electronic survey about precollection vein assessment and line placement, care, and removal in autologous and allogeneic donors. It was distributed to >5,000 possible participants, with one response analyzed per institution. Results: One hundred centers performing autologous and/or allogeneic procedures provided adequate responses for analysis. Donor vein assessment is most often performed by apheresis staff more than 1 week prior to collection. For patients with questionable access, the next step performed most often is secondary assessment for autologous procedures and CVC placement for allogeneic procedures. Most centers use interventional radiology to place CVCs in jugular veins on collection day with placement verification through electronic medical records. Verbal and written postinsertion CVC care instructions are routinely provided. The apheresis team frequently provides postinsertion CVC care for autologous patients. Heparin is used most often for CVC lock. When used, tissue plasminogen activator is usually instilled for up to 60 min. Conclusion: These data summarize the largest single survey of donor vein assessment at institutions performing HPC collections by apheresis. The variations identified in donor venous access practice warrant further investigation and consensus to establish best practices. J. Clin. Apheresis 31:529–534, 2016.

Original languageEnglish (US)
Pages (from-to)529-534
Number of pages6
JournalJournal of Clinical Apheresis
Volume31
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Blood Component Removal
Hematopoietic Stem Cells
Central Venous Catheters
Tissue Donors
Veins
Interventional Radiology
Electronic Health Records
Jugular Veins
Tissue Plasminogen Activator
Practice Guidelines
Heparin
Surveys and Questionnaires
Patient Care
Transplantation

Keywords

  • Apheresis
  • HPC
  • stem cell collection
  • Venous Access

ASJC Scopus subject areas

  • Hematology

Cite this

O'Leary, M. F., Dunbar, N. M., Kim, H. C., Draper, N. L., Linenberger, M., Schwartz, J., ... Park, Y. A. (2016). Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee. Journal of Clinical Apheresis, 31(6), 529-534. https://doi.org/10.1002/jca.21445

Venous access for hematopoietic progenitor cell collection : An international survey by the ASFA HPC donor subcommittee. / O'Leary, Mandy Flannery; Dunbar, Nancy M.; Kim, Haewon C.; Draper, Nicole L.; Linenberger, Michael; Schwartz, Joseph; Miller, Yvette; Murtaugh, Ally; West, F. Bernadette; Fernando, Leonor P; Park, Yara A.

In: Journal of Clinical Apheresis, Vol. 31, No. 6, 01.12.2016, p. 529-534.

Research output: Contribution to journalArticle

O'Leary, MF, Dunbar, NM, Kim, HC, Draper, NL, Linenberger, M, Schwartz, J, Miller, Y, Murtaugh, A, West, FB, Fernando, LP & Park, YA 2016, 'Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee', Journal of Clinical Apheresis, vol. 31, no. 6, pp. 529-534. https://doi.org/10.1002/jca.21445
O'Leary, Mandy Flannery ; Dunbar, Nancy M. ; Kim, Haewon C. ; Draper, Nicole L. ; Linenberger, Michael ; Schwartz, Joseph ; Miller, Yvette ; Murtaugh, Ally ; West, F. Bernadette ; Fernando, Leonor P ; Park, Yara A. / Venous access for hematopoietic progenitor cell collection : An international survey by the ASFA HPC donor subcommittee. In: Journal of Clinical Apheresis. 2016 ; Vol. 31, No. 6. pp. 529-534.
@article{76690257a778492884a8cfade0bbf6b4,
title = "Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee",
abstract = "Purpose:: Hematopoietic Progenitor Cell (HPC) collection by apheresis is performed in patients and donors to obtain HPCs for transplantation. Although studies have shown these procedures to be safe, successful collection cannot be performed without establishment of venous access. This project's objective was to ascertain the current practices of donor vein assessment and central venous catheter (CVC) usage. Methods: The American Society for Apheresis (ASFA) HPC subcommittee created an electronic survey about precollection vein assessment and line placement, care, and removal in autologous and allogeneic donors. It was distributed to >5,000 possible participants, with one response analyzed per institution. Results: One hundred centers performing autologous and/or allogeneic procedures provided adequate responses for analysis. Donor vein assessment is most often performed by apheresis staff more than 1 week prior to collection. For patients with questionable access, the next step performed most often is secondary assessment for autologous procedures and CVC placement for allogeneic procedures. Most centers use interventional radiology to place CVCs in jugular veins on collection day with placement verification through electronic medical records. Verbal and written postinsertion CVC care instructions are routinely provided. The apheresis team frequently provides postinsertion CVC care for autologous patients. Heparin is used most often for CVC lock. When used, tissue plasminogen activator is usually instilled for up to 60 min. Conclusion: These data summarize the largest single survey of donor vein assessment at institutions performing HPC collections by apheresis. The variations identified in donor venous access practice warrant further investigation and consensus to establish best practices. J. Clin. Apheresis 31:529–534, 2016.",
keywords = "Apheresis, HPC, stem cell collection, Venous Access",
author = "O'Leary, {Mandy Flannery} and Dunbar, {Nancy M.} and Kim, {Haewon C.} and Draper, {Nicole L.} and Michael Linenberger and Joseph Schwartz and Yvette Miller and Ally Murtaugh and West, {F. Bernadette} and Fernando, {Leonor P} and Park, {Yara A.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/jca.21445",
language = "English (US)",
volume = "31",
pages = "529--534",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Venous access for hematopoietic progenitor cell collection

T2 - An international survey by the ASFA HPC donor subcommittee

AU - O'Leary, Mandy Flannery

AU - Dunbar, Nancy M.

AU - Kim, Haewon C.

AU - Draper, Nicole L.

AU - Linenberger, Michael

AU - Schwartz, Joseph

AU - Miller, Yvette

AU - Murtaugh, Ally

AU - West, F. Bernadette

AU - Fernando, Leonor P

AU - Park, Yara A.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Purpose:: Hematopoietic Progenitor Cell (HPC) collection by apheresis is performed in patients and donors to obtain HPCs for transplantation. Although studies have shown these procedures to be safe, successful collection cannot be performed without establishment of venous access. This project's objective was to ascertain the current practices of donor vein assessment and central venous catheter (CVC) usage. Methods: The American Society for Apheresis (ASFA) HPC subcommittee created an electronic survey about precollection vein assessment and line placement, care, and removal in autologous and allogeneic donors. It was distributed to >5,000 possible participants, with one response analyzed per institution. Results: One hundred centers performing autologous and/or allogeneic procedures provided adequate responses for analysis. Donor vein assessment is most often performed by apheresis staff more than 1 week prior to collection. For patients with questionable access, the next step performed most often is secondary assessment for autologous procedures and CVC placement for allogeneic procedures. Most centers use interventional radiology to place CVCs in jugular veins on collection day with placement verification through electronic medical records. Verbal and written postinsertion CVC care instructions are routinely provided. The apheresis team frequently provides postinsertion CVC care for autologous patients. Heparin is used most often for CVC lock. When used, tissue plasminogen activator is usually instilled for up to 60 min. Conclusion: These data summarize the largest single survey of donor vein assessment at institutions performing HPC collections by apheresis. The variations identified in donor venous access practice warrant further investigation and consensus to establish best practices. J. Clin. Apheresis 31:529–534, 2016.

AB - Purpose:: Hematopoietic Progenitor Cell (HPC) collection by apheresis is performed in patients and donors to obtain HPCs for transplantation. Although studies have shown these procedures to be safe, successful collection cannot be performed without establishment of venous access. This project's objective was to ascertain the current practices of donor vein assessment and central venous catheter (CVC) usage. Methods: The American Society for Apheresis (ASFA) HPC subcommittee created an electronic survey about precollection vein assessment and line placement, care, and removal in autologous and allogeneic donors. It was distributed to >5,000 possible participants, with one response analyzed per institution. Results: One hundred centers performing autologous and/or allogeneic procedures provided adequate responses for analysis. Donor vein assessment is most often performed by apheresis staff more than 1 week prior to collection. For patients with questionable access, the next step performed most often is secondary assessment for autologous procedures and CVC placement for allogeneic procedures. Most centers use interventional radiology to place CVCs in jugular veins on collection day with placement verification through electronic medical records. Verbal and written postinsertion CVC care instructions are routinely provided. The apheresis team frequently provides postinsertion CVC care for autologous patients. Heparin is used most often for CVC lock. When used, tissue plasminogen activator is usually instilled for up to 60 min. Conclusion: These data summarize the largest single survey of donor vein assessment at institutions performing HPC collections by apheresis. The variations identified in donor venous access practice warrant further investigation and consensus to establish best practices. J. Clin. Apheresis 31:529–534, 2016.

KW - Apheresis

KW - HPC

KW - stem cell collection

KW - Venous Access

UR - http://www.scopus.com/inward/record.url?scp=84954288685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954288685&partnerID=8YFLogxK

U2 - 10.1002/jca.21445

DO - 10.1002/jca.21445

M3 - Article

C2 - 26762291

AN - SCOPUS:84954288685

VL - 31

SP - 529

EP - 534

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 6

ER -